Investigating the involvement of C−X−C motif chemokine 5 and P2X7 purinoceptor in ectopic calcification in mouse models of Duchenne muscular dystrophy
Investigating the involvement of C−X−C motif chemokine 5 and P2X7 purinoceptor in ectopic calcification in mouse models of Duchenne muscular dystrophy
Ectopic calcification of myofibers is an early pathogenic feature in patients and animal models of Duchenne muscular dystrophy (DMD). In previous studies using the Dmdmdx-βgeo mouse model, we found that the dystrophin-null phenotype exacerbates this abnormality and that mineralised myofibers are surrounded by macrophages. Furthermore, the P2X7 purinoceptor, functioning in immune cells offers protection against dystrophic calcification. In the present study, by exploring transcriptomic data from Dmdmdx mice, we hypothesised these effects to be mediated by C−X−C motif chemokine 5 (CXCL5) downstream of P2X7 activation. We found that CXCL5 is upregulated in the quadriceps muscles of Dmdmdx-βgeo mice compared to wild-type controls. In contrast, at the cell level, dystrophic (SC5) skeletal muscle cells secreted less CXCL5 chemokine than wild-type (IMO) controls. Although release from IMO cells was increased by P2X7 activation, this could not explain the elevated CXCL5 levels observed in dystrophic muscle tissue. Instead, we found that CXCL5 is released by dystrophin-null macrophages in response to P2X7 activation, suggesting that macrophages are the source of CXCL5 in dystrophic muscles. The effects of CXCL5 upon mineralisation were investigated using the Alizarin Red assay to quantify calcium deposition in vitro. In basal (low phosphate) media, CXCL5 increased calcification in IMO but not SC5 myoblasts. However, in cultures treated in high phosphate media, to mimic dysregulated phosphate metabolism occurring in DMD, CXCL5 decreased calcification in both IMO and SC5 cells. These data indicate that CXCL5 is part of a homoeostatic mechanism regulating intracellular calcium, that CXCL5 can be released by macrophages in response to the extracellular ATP damage-associated signal, and that CXCL5 can be part of a damage response to protect against ectopic calcification. This mechanism is affected by DMD gene mutations.
CXCL5, Duchenne muscular dystrophy, ectopic calcifiication, macrophage, PX27
Rumney, Robin M.H.
fa3de9f8-b604-44e2-9e72-3e57980ce67f
Pomeroy, Joanna
c5b97493-ad09-443a-a90a-2cbee0a9ea08
Górecki, Dariusz C.
6406abcf-0561-40dc-b41f-32f55795eb04
25 June 2024
Rumney, Robin M.H.
fa3de9f8-b604-44e2-9e72-3e57980ce67f
Pomeroy, Joanna
c5b97493-ad09-443a-a90a-2cbee0a9ea08
Górecki, Dariusz C.
6406abcf-0561-40dc-b41f-32f55795eb04
Rumney, Robin M.H., Pomeroy, Joanna and Górecki, Dariusz C.
(2024)
Investigating the involvement of C−X−C motif chemokine 5 and P2X7 purinoceptor in ectopic calcification in mouse models of Duchenne muscular dystrophy.
Journal of Cellular Biochemistry, 125 (8), [e30617].
(doi:10.1002/jcb.30617).
Abstract
Ectopic calcification of myofibers is an early pathogenic feature in patients and animal models of Duchenne muscular dystrophy (DMD). In previous studies using the Dmdmdx-βgeo mouse model, we found that the dystrophin-null phenotype exacerbates this abnormality and that mineralised myofibers are surrounded by macrophages. Furthermore, the P2X7 purinoceptor, functioning in immune cells offers protection against dystrophic calcification. In the present study, by exploring transcriptomic data from Dmdmdx mice, we hypothesised these effects to be mediated by C−X−C motif chemokine 5 (CXCL5) downstream of P2X7 activation. We found that CXCL5 is upregulated in the quadriceps muscles of Dmdmdx-βgeo mice compared to wild-type controls. In contrast, at the cell level, dystrophic (SC5) skeletal muscle cells secreted less CXCL5 chemokine than wild-type (IMO) controls. Although release from IMO cells was increased by P2X7 activation, this could not explain the elevated CXCL5 levels observed in dystrophic muscle tissue. Instead, we found that CXCL5 is released by dystrophin-null macrophages in response to P2X7 activation, suggesting that macrophages are the source of CXCL5 in dystrophic muscles. The effects of CXCL5 upon mineralisation were investigated using the Alizarin Red assay to quantify calcium deposition in vitro. In basal (low phosphate) media, CXCL5 increased calcification in IMO but not SC5 myoblasts. However, in cultures treated in high phosphate media, to mimic dysregulated phosphate metabolism occurring in DMD, CXCL5 decreased calcification in both IMO and SC5 cells. These data indicate that CXCL5 is part of a homoeostatic mechanism regulating intracellular calcium, that CXCL5 can be released by macrophages in response to the extracellular ATP damage-associated signal, and that CXCL5 can be part of a damage response to protect against ectopic calcification. This mechanism is affected by DMD gene mutations.
Text
J of Cellular Biochemistry - 2024 - Rumney - Investigating the Involvement of C X C Motif Chemokine 5 and P2X7 Purinoceptor
- Version of Record
More information
Accepted/In Press date: 6 June 2024
Published date: 25 June 2024
Keywords:
CXCL5, Duchenne muscular dystrophy, ectopic calcifiication, macrophage, PX27
Identifiers
Local EPrints ID: 498139
URI: http://eprints.soton.ac.uk/id/eprint/498139
ISSN: 0730-2312
PURE UUID: d5d216b6-066b-4c25-afbf-5e57b3c73e20
Catalogue record
Date deposited: 11 Feb 2025 17:32
Last modified: 22 Aug 2025 02:13
Export record
Altmetrics
Contributors
Author:
Robin M.H. Rumney
Author:
Joanna Pomeroy
Author:
Dariusz C. Górecki
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics